KRCC1: A potential therapeutic target in ovarian cancer.
Dwivedi SKD, Shameer K, Dey A, Mustafi SB, Xiong X, Bhattacharya U, Neizer-Ashun F, Rao G, Wang Y, Ivan C, Yang D, Dudley JT, Xu C, Wren JD, Mukherjee P, Bhattacharya R.
Dwivedi SKD, et al. Among authors: bhattacharya u, bhattacharya r.
FASEB J. 2020 Feb;34(2):2287-2300. doi: 10.1096/fj.201902259R. Epub 2019 Dec 23.
FASEB J. 2020.
PMID: 31908025
Free PMC article.